These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11044735)

  • 1. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes.
    Miller DK; Crooks PA; Dwoskin LP
    Neuropharmacology; 2000 Oct; 39(13):2654-62. PubMed ID: 11044735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices.
    Wilkins LH; Haubner A; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1088-96. PubMed ID: 12023541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP; Teng L; Buxton ST; Crooks PA
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine.
    Terry AV; Williamson R; Gattu M; Beach JW; McCurdy CR; Sparks JA; Pauly JR
    Neuropharmacology; 1998; 37(1):93-102. PubMed ID: 9680262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes.
    Wilkins LH; Miller DK; Ayers JT; Crooks PA; Dwoskin LP
    AAPS J; 2006 Jan; 7(4):E922-30. PubMed ID: 16594645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
    Teng L; Crooks PA; Buxton ST; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Nov; 283(2):778-87. PubMed ID: 9353398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
    Rao TS; Correa LD; Lloyd GK
    Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
    Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
    J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Feb; 111(2):406-13. PubMed ID: 8004384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
    Sidhpura N; Redfern P; Wonnacott S
    Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nornicotine, a nicotine metabolite and tobacco alkaloid: desensitization of nicotinic receptor-stimulated dopamine release from rat striatum.
    Dwoskin LP; Teng LH; Crooks PA
    Eur J Pharmacol; 2001 Sep; 428(1):69-79. PubMed ID: 11779039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Smith AM; Dhawan GK; Zhang Z; Siripurapu KB; Crooks PA; Dwoskin LP
    Biochem Pharmacol; 2009 Oct; 78(7):889-97. PubMed ID: 19631612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices.
    Green TA; Crooks PA; Bardo MT; Dwoskin LP
    Biochem Pharmacol; 2001 Dec; 62(12):1597-603. PubMed ID: 11755112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
    Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
    AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.